We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+29.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$9.47B
AUM Growth
+$451M
Cap. Flow
+$1.13B
Cap. Flow %
11.96%
Top 10 Hldgs %
21.59%
Holding
903
New
107
Increased
255
Reduced
393
Closed
103

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$51.9M
2
MRK icon
Merck
MRK
+$50.9M
3
DHR icon
Danaher
DHR
+$45.3M
4
TMO icon
Thermo Fisher Scientific
TMO
+$37.8M
5
JD icon
JD.com
JD
+$37.7M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$103M
2
BABA icon
Alibaba
BABA
+$98.6M
3
CRM icon
Salesforce
CRM
+$62.5M
4
BMY icon
Bristol-Myers Squibb
BMY
+$59.4M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$48.6M

Sector Composition

Rank Sector Weight
1 Healthcare 34.61%
2 Technology 20.94%
3 Consumer Discretionary 8.9%
4 Financials 8.59%
5 Communication Services 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HRC
151
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$15.9M 0.17%
+144,759
New +$15.2M
TENB icon
152
Tenable Holdings
TENB
$3.61B
$15.8M 0.17%
530,219
+24,356
+5% +$662K
AMTD
153
DELISTED
TD Ameritrade Holding Corp
AMTD
$15.4M 0.16%
424,470
+316,067
+292% +$11.9M
TPTX
154
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$15.4M 0.16%
238,081
+85,441
+56% +$4.93M
HON icon
155
Honeywell
HON
$77.5B
$15.3M 0.16%
112,134
+21,698
+24% +$2.87M
CMCSA icon
156
Comcast
CMCSA
$81.5B
$15.2M 0.16%
389,837
-64,808
-14% -$2.47M
EBAY icon
157
eBay
EBAY
$50.1B
$15.2M 0.16%
288,895
+136,596
+90% +$5.77M
DCPH
158
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$15M 0.16%
251,715
+251,701
+1,797,864% +$13.5M
XNCR icon
159
Xencor
XNCR
$1.48B
$15M 0.16%
463,092
+280,916
+154% +$8.61M
IONS icon
160
Ionis Pharmaceuticals
IONS
$9.24B
$15M 0.16%
253,700
-8,000
-3% -$445K
CTXS
161
DELISTED
Citrix Systems Inc
CTXS
$14.9M 0.16%
100,511
+18,881
+23% +$2.72M
GWPH
162
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$14.7M 0.16%
119,962
+44,151
+58% +$5.01M
EE
163
DELISTED
El Paso Electric Company
EE
$14.7M 0.16%
219,615
+22,467
+11% +$1.52M
ITCI
164
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$14.6M 0.15%
570,000
-323,000
-36% -$6.54M
MRSN
165
DELISTED
Mersana Therapeutics
MRSN
$13.9M 0.15%
+23,830
New +$8.14M
ARWR icon
166
Arrowhead Research
ARWR
$12.2B
$13.9M 0.15%
321,146
+38,638
+14% +$1.36M
MNTA
167
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$13.5M 0.14%
+407,020
New +$13M
ARGX icon
168
argenx
ARGX
$56.2B
$13.5M 0.14%
59,907
+51,586
+620% +$9.16M
MYOK
169
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$13.3M 0.14%
138,000
+67,500
+96% +$5.63M
MGNX icon
170
MacroGenics
MGNX
$254M
$13.1M 0.14%
468,433
-279,330
-37% -$4.85M
CIB icon
171
Grupo Cibest SA
CIB
$20.9B
$12.9M 0.14%
491,378
+170,474
+53% +$4.47M
HCA icon
172
HCA Healthcare
HCA
$86.9B
$12.9M 0.14%
133,194
+23,185
+21% +$2.41M
BAP icon
173
Credicorp
BAP
$30.9B
$12.8M 0.14%
95,800
+55,200
+136% +$7.86M
SPY icon
174
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$782B
$12.7M 0.13%
+2,808,500
New +$822M
CCI icon
175
Crown Castle
CCI
$32.4B
$12.7M 0.13%
75,733
+33,959
+81% +$5.47M
5 6
7
8 9

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2020 Portfolio in Review

As of Q2 2020, Candriam SCA held 903 positions worth $9.47B, up 5% from $9.02B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA deployed $1.13B of net new capital in Q2 2020, opening 107 new positions and adding to 255 existing holdings. Its largest new stake was JD.com: 744,410 shares worth $44.8M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $103M trimmed.

  • Candriam SCA's largest Q2 2020 buy was JD.com: 744,410 shares worth $44.8M.
  • Candriam SCA added most to Blueprint Medicines in Q2 2020, an estimated $51.9M increase.
  • Candriam SCA's biggest Q2 2020 reduction was Regeneron Pharmaceuticals, cutting an estimated $103M.
  • Candriam SCA fully exited Salesforce in Q2 2020, selling an estimated $62.5M.
  • Candriam SCA's ten largest holdings make up 22% of its $9.47B portfolio in Q2 2020.
  • Candriam SCA opened 107 new positions and closed 103 in Q2 2020.
  • Candriam SCA's portfolio value rose 5% quarter-over-quarter to $9.47B.

Based on Candriam SCA's 13F filing for Q2 2020, filed 23 Jul 2020.